• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Pediatr Infect Dis J . Maternal, Infant, and Breast Milk Antibody Response Following COVID-19 Infection in Early Versus Late Gestation

tetano

Editor, Senior Moderator
Pediatr Infect Dis J


. 2022 Dec 12.
doi: 10.1097/INF.0000000000003802. Online ahead of print.
Maternal, Infant, and Breast Milk Antibody Response Following COVID-19 Infection in Early Versus Late Gestation


Elisha M Wachman[SUP] 1 [/SUP], Jennifer Snyder-Cappione[SUP] 2 [/SUP], Jean Devera[SUP] 3 [/SUP], Jeffery Boateng[SUP] 1 [/SUP], Yashoda Dhole[SUP] 3 [/SUP], Katherine Clarke[SUP] 2 [/SUP], Rachel R Yuen[SUP] 2 [/SUP], Samantha E Parker[SUP] 4 [/SUP], Jessica Hunnewell[SUP] 4 [/SUP], Renee Ferraro[SUP] 1 [/SUP], Sigride Jean-Sicard[SUP] 1 [/SUP], Elizabeth Woodard[SUP] 1 [/SUP], Alice Cruikshank[SUP] 1 [/SUP], Bharati Sinha[SUP] 1 [/SUP], Ruby Bartolome[SUP] 1 [/SUP], Elizabeth D Barnett[SUP] 1 [/SUP], Christina Yarrington[SUP] 5 [/SUP], Elizabeth S Taglauer[SUP] 1 [/SUP], Vishakha Sabharwal[SUP] 1 [/SUP]



Affiliations

Abstract

Background: Coronavirus disease 2019 [severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)] infection at varying time points during the pregnancy can influence antibody levels after delivery. We aimed to examine SARS-CoV-2 IgG, IgM and IgA receptor binding domain of the spike protein and nucleocapsid protein (N-protein) reactive antibody concentrations in maternal blood, infant blood and breastmilk at birth and 6 weeks after SARS-CoV-2 infection in early versus late gestation.
Methods: Mothers with SARS-CoV-2 infection during pregnancy were enrolled between July 2020 and May 2021. Maternal blood, infant blood and breast milk samples were collected at delivery and 6 weeks postpartum. Samples were analyzed for SARS-CoV-2 spike and N-protein reactive IgG, IgM and IgA antibodies. Antibody concentrations were compared at the 2 time points and based on trimester of infection ("early" 1st/2nd vs. "late" 3rd).
Results: Dyads from 20 early and 11 late trimester infections were analyzed. For the entire cohort, there were no significant differences in antibody levels at delivery versus 6 weeks with the exception of breast milk levels which declined over time. Early gestation infections were associated with higher levels of breastmilk IgA to spike protein (P = 0.04). Infant IgG levels to spike protein were higher at 6 weeks after late infections (P = 0.04). There were strong correlations between maternal and infant IgG levels at delivery (P < 0.01), and between breastmilk and infant IgG levels.
Conclusions: SARS-CoV-2 infection in early versus late gestation leads to a persistent antibody response in maternal blood, infant blood and breast milk over the first 6 weeks after delivery.
 
Back
Top Bottom